BDBM50111407 3-[2-Oxo-4-(8-pyridin-4-yl-2,8-diaza-spiro[4.5]decane-2-carbonyl)-piperazin-1-yl]-propionic acid::CHEMBL276405
SMILES: OC(=O)CCN1CCN(CC1=O)C(=O)N1CCC2(C1)CCN(CC2)c1ccncc1
InChI Key: InChIKey=DDXJSWMWHOOAKR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50111407 (3-[2-Oxo-4-(8-pyridin-4-yl-2,8-diaza-spiro[4.5]dec...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 238 | n/a | n/a | n/a | n/a | n/a | n/a |
COR Therapeutics, Inc. Curated by ChEMBL | Assay Description In vitro activity to block the binding of fibrinogen to purified human fibrinogen receptor. | Bioorg Med Chem Lett 12: 1103-7 (2002) BindingDB Entry DOI: 10.7270/Q2H131BN | |||||||||||
More data for this Ligand-Target Pair |